Browse Category

Financial Updates News 12 November 2025 - 16 November 2025

Wesfarmers (ASX: WES) Share Price: What Investors Need to Know Before the ASX Opens on 17 November 2025

Wesfarmers (ASX: WES) Share Price: What Investors Need to Know Before the ASX Opens on 17 November 2025

Australia’s retail-conglomerate heavyweight Wesfarmers Limited (ASX: WES) heads into Monday’s session with a mix of record profits, a large capital return, fresh lithium momentum and a few growing regulatory and cost headwinds all jostling for investors’ attention. Below is a pre‑open briefing on the key numbers, news and themes to have on your radar before trading resumes on Monday, 17 November 2025. Key points Wesfarmers share price snapshot before the 17 November open Wesfarmers closed Friday, 14 November 2025 at A$81.13, down 0.44% on the day, after a volatile fortnight for the broader ASX. wesfarmers.com.au+2ABC+2 Over the past 12–18 months,
16 November 2025
Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Japan Stocks Today: What to Know Before the Tokyo Open (Nov 17, 2025) — GDP at 8:50 JST, Yen Near 154, Stimulus in Focus

Tokyo’s cash equity session opens at 9:00 a.m. JST, with Japan’s first estimate of Q3 GDP landing just 10 minutes earlier—setting the tone for Monday’s trade. Japan Exchange Group+1 Snapshot before the bell 1) The data drop that could swing the open: Q3 GDP (8:50 a.m. JST) Japan’s first preliminary GDP for July–September lands minutes before the opening auction. A Reuters poll flagged the risk of Japan’s first contraction in six quarters amid tariff headwinds and soft exports; the median call was a −0.6% q/q (−2.5% annualized) setback. Watch the private consumption and net exports lines for read‑through to retailers
16 November 2025
Microsoft (MSFT) Stock Outlook (Nov 2025): AI-Powered Growth, Strong Earnings, and 2026 Forecast

Microsoft Stock: What to Know Before the Market Opens on Monday, November 17, 2025

MSFT closed last week with momentum, a packed AI and product news calendar, and a dividend catalyst on deck. Here’s your concise, fact‑checked briefing for the open. The quick take 1) Price and positioning heading into Monday Microsoft shares closed at $510.18 on Friday with ~28.5M shares traded. The stock’s 52‑week range sits at $344.79 to $555.45, leaving room to the prior high if Ignite or other AI news lands well. Remember, the company crossed $4T market value on July 31, 2025, underscoring how tightly near‑term moves are tied to generative‑AI execution and capacity. Reuters+3Nasdaq+3MacroTrends+3 Numbers at a glance (as
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta Stock Today, November 14, 2025: Tiger Global Exit, AI Spending Fears and Scam-Ad Revelations Leave META Flat

Meta Platforms (NASDAQ: META) ended Friday’s session almost unchanged despite a barrage of headlines about hedge-fund selling, AI-fueled spending plans, new data centers and fresh scrutiny of its ad business. The stock closed around $609.46, giving the company a market value of roughly $1.5 trillion. That leaves META about 23% below its August peak near $790, but still roughly 27% above its 52‑week low around $480.  Google+2Stocktwits+2 After the closing bell, Meta was trading just a touch higher in thin after-hours action, suggesting that traders are still digesting a flood of AI- and regulation-related news rather than making big directional bets.  StockAnalysis+1 Meta stock
Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025

Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025

On Friday, November 14, 2025, Cytek Biosciences, Inc. (NASDAQ: CTKB) is trading sharply higher, extending a strong two‑week run helped by fresh industry recognition, product awards and steady (if modest) earnings growth. As of the latest trade this afternoon, CTKB is changing hands around $4.99, up roughly 9% intraday, with the stock appearing on Nasdaq’s list of notable movers even as the broader U.S. market trades lower. Benzinga Below is a breakdown of all the key Cytek‑related news impacting CTKB today, November 14, 2025, plus the most important headlines from the past few days that are driving sentiment. 1. What’s
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4 HIMS stock today: price, move and context As of early afternoon on Friday, November 14, 2025, Hims & Hers shares are: Trading has been volatile around HIMS in recent sessions,
IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (NASDAQ: IREN) – the Australian-born Bitcoin miner turned renewable-powered AI data‑center operator – is having another wild session on Friday, 14 November 2025. Despite landing a landmark US$9.7 billion AI cloud contract with Microsoft earlier this month and reporting record quarterly results last week, the stock is down sharply again today as investors reassess the risks behind its breakneck expansion. IREN stock today: sharp selloff after a parabolic year As of Friday afternoon, IREN shares are trading around $48.65, down approximately 12.7% over the last 24 hours. That move caps a bruising week in which the stock has
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Pre-Market Today (Nov. 14, 2025): What to Know Before the US Market Opens

Key Takeaways Before the Bell This article is for information and news purposes only and is not financial advice or a recommendation to buy or sell any security. AMD Stock Pre-Market Today: Price, Move and Valuation As of early U.S. pre-market trading on Friday, November 14, 2025, AMD’s last indicated pre-market price is about $242.51, down roughly $5.45 (-2.2%) from Thursday’s close of $247.96. Pre-market volume is reported around 266,600 shares, which is meaningful but still far below regular-session turnover.  Yahoo Finance+1 Thursday’s regular session already saw a sharp move: AMD finished at $247.96, about 4.2% lower on the day as part of a broader tech selloff, and roughly 10% off its recent
Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings Inc. (NASDAQ: SOND), once pitched as a tech‑driven rival to Airbnb and a partner of Marriott International, is now in full collapse mode. The company is winding down operations, expecting to file for Chapter 7 bankruptcy of its U.S. business and begin insolvency proceedings abroad, while guests around the world report being told to leave their rooms with only hours’ notice. 6abc Philadelphia+3Yahoo Finance+3Stock Titan+3 SOND stock today: extreme volatility under 25 cents As of this afternoon (Nov. 13, 2025), SOND stock is trading around $0.17, up modestly on the day but still hovering near all‑time lows after
Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio, Inc. (NASDAQ: KRRO) is at the center of one of biotech’s biggest shake‑ups of 2025. After releasing mixed early data from its lead RNA‑editing program, KRRO‑110, the company has announced deep layoffs, a strategic pivot in its pipeline and a 12‑month pause in its high‑profile collaboration with Novo Nordisk. The stock has responded with a brutal collapse. As of Thursday, 13 November 2025, here’s a full rundown of everything that has hit the tape around Korro Bio today and what it could mean for KRRO shareholders. KRRO stock: from low‑30s to single digits in a day Korro Bio
Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Live price snapshotAviva (LSE: AV.) traded at 664.60p at 09:53 GMT, down 28.00p (-4.04%) versus Wednesday’s close. Intraday, the stock has moved between 656.08p and 675.99p; its 52‑week range stands at 451.90p–698.40p. Figures are delayed and time‑stamped. Financial Times Markets+1 What’s moving the sharesThe drop follows Aviva’s third‑quarter trading update and “In Focus” presentation, which raised medium‑term ambitions and nearly doubled expected cost savings from the Direct Line acquisition. Management now targets operating EPS growth of 11% (2025–2028 CAGR), IFRS ROE above 20% by 2028, and >£7bn cash remittances over 2026–2028. Cost synergies from Direct Line are lifted to £225m
Shell’s $2 Billion Nigeria Gas Gamble Ignites LNG Boom Amid $8 B Investment Surge

Shell Stock Price Today (12 Nov 2025): SHEL ADR edges lower as oil slides; London closes at 2,909p amid fresh buyback and Volta Media sale

All figures and news items are for Wednesday, November 12, 2025. Shell stock at a glance (real‑time snapshot) Note: Each U.S. SHEL ADR represents two ordinary shares traded in London/Amsterdam. Nasdaq What moved Shell’s share price today 1) Oil prices dropped on a new OPEC outlook Crude fell sharply after an OPEC report signaled supply and demand could be broadly in balance in 2026, sapping sentiment across energy equities. By early afternoon U.S. time, Brent was down to $62.61 (–3.9%) and WTI to $58.46 (–4.2%). For integrated majors like Shell, lower crude typically pressures earnings expectations for upstream and trading.
12 November 2025
Go toTop